This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Morton, S. Articles by Lader, M. Search for Related Content PubMed Articles by Morton, S. Articles by Lader, M. Social Bookmarking                         What's this?

Buspirone treatment as an aid to benzodiazepine withdrawal

Institute of Psychiatry, University of London, London SE5 8AF, UK

M. Lader

Institute of Psychiatry, University of London, London SE5 8AF, UK

Twenty four long-term benzodiazepine users were allocated randomly to treatment with either buspirone (mean dose 25 mg/day) or placebo, prior to tapering off the benzodiazepine over 6 weeks. In both groups, six out of 12 patients successfully completed withdrawal. However, buspirone-treated patients tended to have lower anxiety levels than placebo-treated patients. The amount of previous benzodiazepine usage predicted outcome.

Key Words: benzodiazepines • dependence • buspirone • anxiety

Journal of Psychopharmacology, Vol. 9, No. 4, 331-335 (1995)
DOI: 10.1177/026988119500900407


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				A. R. Lingford-Hughes, S. Welch, and D. J. Nutt Evidence-Based Guidelines for the Pharmacological Management of Substance Misuse, Addiction and Comorbidity: Recommendations from the British Association for Psychopharmacology J Psychopharmacol, September 1, 2004; 18(3): 293 - 335. [PDF]